Prognostic value of haematological markers such as neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in small cell lung cancer.

M. Aparicio Vicente (Murcia, Spain), E. García Pachón (Elche, Spain), S. Ruiz Martínez (Murcia, Spain), L. Fernández Mula (Murcia, Spain)

Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Session: Prognostic and predictive factors: treatment of lung cancer
Session type: E-poster session
Number: 1740
Disease area: Thoracic oncology

Congress or journal article abstractE-poster

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
M. Aparicio Vicente (Murcia, Spain), E. García Pachón (Elche, Spain), S. Ruiz Martínez (Murcia, Spain), L. Fernández Mula (Murcia, Spain). Prognostic value of haematological markers such as neutrophil-lymphocyte ratio (NLR) and platelet-lymphocyte ratio (PLR) in small cell lung cancer.. 1740

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
The prognostic impact of the neutrophil-to-lymphocyte ratio (NLR) and platelet-to-lymphocyte ratio (PLR) in patients with non-small cell lung cancer
Source: International Congress 2016 – Lung cancer and immune cells: friends or foes?
Year: 2016

Prognostic value of neutrophil to lymphocyte ratio in small cell lung cancer
Source: Virtual Congress 2020 – Prognostic and predictive factors: treatment of lung cancer
Year: 2020


The prognostic value of the albumin-to-fibrinogen ratio in lung cancer patients.
Source: International Congress 2019 – Biology and prognosis of lung cancer
Year: 2019


Prognostic value of neutrophil-to-lymphocyte ratio in hospitalized patients with COVID-19
Source: Virtual Congress 2021 – COVID - 19
Year: 2021


Platelet-to-lymphocyte ratio (PLR) as a predictor of Covid-19 pneumonia progression
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021


Diagnostic value of CD4/CD8 ratio in induced sputum (IS) in interstitial lung disease (ILD)
Source: Annual Congress 2004 - Pathobiological and clinical investigations in interstitial lung diseases
Year: 2004


Are white blood cells count, neutrophil-to-lymphocyte ratio, lymphocyte to monocyte ratio and platelet-to-lymphocyte ratio associated with severe COVID-19 infection?
Source: Virtual Congress 2021 – COVID - 19
Year: 2021


Is neutrophil/lymphocyte ratio at the time of diagnosis a valuable prognostic factor in non-small cell lung cancer?
Source: International Congress 2018 – Lung cancer: novel prognostic markers and scores
Year: 2018

Selected blood parameters of inflammation (circulating immune complexes, CIC, C-reactive protein, CRP, neutrophil/ lymphocyte ratio and platelet/lymphocyte ratio) in patients with chronic obstructive pulmonary disease (COPD)
Source: Virtual Congress 2020 – Clinical characteristics and diagnostic tools for phenotyping asthma and COPD
Year: 2020

Lymphocyte-to-Monocyte ratio (LMR) and Platelet-to-lymphocyte (PLR) ratio levels as a predictors of lung failure in severe Covid-19 pneumonia patients (pts)
Source: Virtual Congress 2021 – COVID - 19: lessons learned
Year: 2021


Preoperative cell counts of white blood cell, neutrophil, lymphocyte and neutrophil/lymphocyte ratio as a predictive parameter of survival rate after complete resection for non-small cell lung cancer
Source: International Congress 2016 – Prognostic variables in lung cancer I
Year: 2016

Prognostic significance of plasma D-dimer (DD) in lung cancer
Source: Eur Respir J 2002; 20: Suppl. 38, 72s
Year: 2002

Malignant mesothelioma, are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio prognostic indicator parameters as reliable?
Source: International Congress 2015 – Mediastinal tumors, malignant pleural mesothelioma and other rare tumors
Year: 2015

A meta-analysis assessing the prognostic value of neutrophil to lymphocyte ratio in lung metastasectomy for colorectal cancer
Source: Virtual Congress 2021 – Innovation in thoracic surgery
Year: 2021



The prognosis of the neutrophil to lymphocyte ratio and platelet to lymphocyte ratio in lung cancer and the association with treatment: a retrospective study>
Source: International Congress 2017 – Lung cancer - clinical research: scientific pearls from the bedside
Year: 2017

Neutrophil-to-lymphocyte ratio in IPF patients: a novel prognostic biomarker?
Source: Virtual Congress 2020 – Prognosis and biomarkers of idiopathic pulmonary fibrosis
Year: 2020


Prognostic value of neutrophil to lymphocyte ratio in patients with advanced non-small cell lung cancer
Source: Virtual Congress 2021 – Therapy of lung cancer
Year: 2021


Defining the role of neutrophil-to-lymphocyte ratio in COPD patients
Source: Virtual Congress 2020 – Prognosis and integrated management of COPD
Year: 2020

Exploring the neutrophil/lymphocyte and platelet/lymphocyte ratios as biomarkers for lung cancer development
Source: International Congress 2015 – Lung cancer: prognostic factors and features of oncogene-driven tumours
Year: 2015


Lymphocyte-to-monocyte ratio (LMR) as a predictor of Covid-19 pneumonia progression
Source: Virtual Congress 2021 – COVID - 19 biomarkers
Year: 2021